Human immunodeficiency virus (HIV)
Herpes simplex viruses (HSV 1&2)
Hepatitis B
Helping Patients Break Free from Viral Diseases
Founded in 2015, Excision BioTherapeutics is a biotechnology company leveraging proprietary, CRISPR-based gene-editing technology and collaborative partnerships with leading research institutions to develop and advance transformative therapies designed to improve the lives of patients living with viral infectious diseases.--
About Our Company